SCHEMBL3501333

SCHEMBL3501333

NC(=O)Cc1nnc(S(N)(=O)=O)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.56
CA2 P00918 17/20 0.47
CA1 P00915 16/20 0.47
CA9 Q16790 10/20 0.47
CA4 P22748 9/20 0.47
CA5A P35218 5/20 0.47
CA7 P43166 5/20 0.47
CA5B Q9Y2D0 5/20 0.47
CA12 O43570 4/20 0.47
CA6 P23280 4/20 0.47
CA13 Q8N1Q1 4/20 0.47
CA14 Q9ULX7 4/20 0.47
CA3 P07451 3/20 0.45
MEN1 O00255 1/20 0.45
CA11 O75493 1/20 0.45
THRB P10828 1/20 0.45
BLM P54132 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11119776 0.82 CA2 (0.45) CA2CA1CA9CA4CA5A
SCHEMBL11123516 0.81 CA2 (0.44) CA2CA1CA9CA4CA5A
SCHEMBL10108473 0.76 CA2 (0.55) CA2CA1CA9CA4CA5A
SCHEMBL9368380 0.75 CA2 (0.55) CA2CA1CA9CA4CA5A
SCHEMBL10769562 0.75 F2 (0.62) F2MEN1SMN1; SMN2
SCHEMBL10108481 0.73 CA2 (0.45) CA2CA1CA9CA4CA5A
SCHEMBL27249244 0.73 CA2 (0.55) CA2CA1CA9CA4CA5A
SCHEMBL15149636 0.72 F2 (0.64) F2CA2MEN1KMT2ASMN1; SMN2
SCHEMBL9796194 0.72 CA2 (0.71) CA2CA1CA9CA4CA5A
SCHEMBL4639363 0.71 CA1 (0.52) CA2CA1CA9CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060222997-A1 Adhesion improver for photosensitive resin composition and photosensitive resin composition containing same KOBAYASHI SATOSHI 2006-10-05 US claimed
EP-4543431-A1 METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR APNIMED, INC. (DELAWARE) (US) 2025-04-30 EP disclosed
EP-4429649-A1 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CENTRAL HYPOVENTILATION APNIMED, INC. (DELAWARE) (US) 2024-09-18 EP disclosed
WO-2023249924-A1 METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR APNIMED, INC. (DELAWARE) (US) 2023-12-28 WO disclosed
WO-2023086433-A1 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CENTRAL HYPOVENTILATION APNIMED, INC. (DELAWARE) (US) 2023-05-19 WO disclosed
WO-2023086431-A1 METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA APNIMED, INC. (DELAWARE) (US) 2023-05-19 WO disclosed
CN-106019830-B Resist composition and method for producing resist pattern 住友化学株式会社 2021-08-20 CN disclosed
EP-3554490-A1 PHARMACEUTICAL COMBINATION COMPRISING A T-TYPE CALCIUM CHANNEL BLOCKER Idorsia Pharmaceuticals Ltd (CH) 2019-10-23 EP disclosed
WO-2018109152-A1 PHARMACEUTICAL COMBINATION COMPRISING A T-TYPE CALCIUM CHANNEL BLOCKER IDORSIA PHARMACEUTICALS LTD (CH) 2018-06-21 WO disclosed
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
CN-1802608-B Adhesion improver for photosensitive resin composition and photosensitive resin composition containing same AZ ELECTRONIC MATERIALS JAPAN 2010-06-02 CN disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 EP disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 US disclosed
EP-1776115-A2 USE OF ORGANIC COMPOUNDS Novartis AG (CH) 2007-04-25 EP disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 WO disclosed
US-20060222997-A1 Adhesion improver for photosensitive resin composition and photosensitive resin composition containing same KOBAYASHI SATOSHI 2006-10-05 US disclosed
CN-1802608-A Adhesion improver for photosensitive resin composition and photosensitive resin composition containing same AZ ELECTRONIC MATERIALS JAPAN (JP) 2006-07-12 CN disclosed
EP-1647860-A1 ADHESION IMPROVER FOR PHOTOSENSITIVE RESIN COMPOSITION AND PHOTOSENSITIVE RESIN COMPOSITION CONTAINING SAME AZ Electronic Materials (Japan) K.K. (JP) 2006-04-19 EP disclosed
WO-2005037278-A2 TBENAZPRIL AND AMLODIPINE FOR REDUCING CARDIOVASCULAR MORBIDITY NOVARTIS AG (CH) 2005-04-28 WO disclosed